8NH-18106-77965
4 vaccinations
3 coded responses
22 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 231 / VA
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Registered in v-safe
- 2021-02-05
- 2021-02-10
- 2021-02-16
- 2021-02-23
- 2021-03-03
- 2021-03-09
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-04-27
- 2021-04-27
- 2021-04-30
- 2021-06-16
- 2021-09-15
-
2021-10-25
Dose 3 — Pfizer-BioNTech
-
2022-03-17
Survey response — 12 months, dose 2MedDRA: Decreased interest, Fatigue, Rhinorrhoea, Somnolence — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mid January 2022, had 3 days of extreme tiredness and lack of interest in anything. I slept a lot of hours. Also had a runny nose most of the day, clear liquid. Did not check temperature, thought it was just a seasonal thing - allergies, stress.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-02
- 2022-11-03
- 2022-11-04
- 2022-11-13
- 2022-11-20
- 2022-11-28
-
2022-12-02
Survey response — day 35, dose 4MedDRA: Office visit, Rash — Feeling: FairFree text: The rash at my left ankle area has had a baby which is growing somewhat rapidly. My oncologist suggested I use a mixture of triamcinolone cream with desitin. I have been using it for about a week but it has not stopped the baby from growing.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-11
-
2023-02-01
Survey response — 3 months, dose 4MedDRA: Eye infection, Hordeolum, Hypersensitivity vasculitis, Lichen planus, Pain, Swelling of eyelid, Visual impairment — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech | |
| 3 | 2021-10-25 | Pfizer-BioNTech | No |
| 4 | 2022-10-28 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 12 months, dose 2
Symptoms: Mid January 2022, had 3 days of extreme tiredness and lack of interest in anything. I slept a lot of hours. Also had a runny nose most of the day, clear liquid. Did not check temperature, thought it was just a seasonal thing - allergies, stress.
Release 12 — day 35, dose 4
Symptoms: The rash at my left ankle area has had a baby which is growing somewhat rapidly. My oncologist suggested I use a mixture of triamcinolone cream with desitin. I have been using it for about a week but it has not stopped the baby from growing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Decreased interest | · | · | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hordeolum | · | · | ✓ |
| SD | Hypersensitivity vasculitis | · | · | ✓ |
| SD | Lichen planus | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Swelling of eyelid | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release